HLB Genex187420

Largest holderHLB13.76%$7.5M

Filed holders135% or more, plus insiders

Price and institutional trades

1Y 2Y

$1.44−34.1%1Y

DecJanFebMarAprMayJunJulAugSepOctNov

Holders

$8.7M · direct 13.76% · indirect 2.25% · 2026-10-1516.01%

Direct13.76%
HLB Therapeutics 13.64% → HLB Genex 1.74%0.24%
HLB bioStep 14.51% → HLB Panagene 7.14% → HLB Genex 6.24%0.06%
HLB Therapeutics 13.64% → HLB Panagene 1.30% → HLB Genex 6.24%0.01%
HLB Panagene 8.44% → HLB Genex 6.24%0.53%
HLB innoVation 16.07% → HLB Panagene 1.30% → HLB Genex 6.24%0.01%
HLB bioStep 14.51% → HLB innoVation 2.02% → HLB Genex 6.18%0.02%
HLB Life Science 16.81% → HLB Pharmaceutical 14.05% → HLB innoVation 7.84% → HLB Genex 6.18%0.01%
HLB innoVation 16.07% → HLB Genex 6.18%0.99%
HLB Life Science 16.81% → HLB innoVation 7.89% → HLB Genex 6.18%0.08%
HLB Life Science 16.81% → HLB Genex 1.74%0.29%

$3.0M · 2026-07-206.44%−0.75pp

$3.4M · 2026-10-15

Companies held by HLB Genex

HLB$3.7M · 2026-08-200.13%HLB Pep$3.2M · 2026-08-2011.13%

Filings

Filed	Changed	Before → after	Amount	Avg buy price
2026-10-15	2026-10-14	38.55 → 39.10%	+$348K	$1.63	Filing
2026-09-17	2026-09-12	38.32 → 38.55%	-	$1.60	Filing
2026-07-29	-	2.33 → 2.48%	+$58K	-	Filing
2026-07-22	2026-07-21	38.13 → 38.32%	+$94K	$1.13	Filing
2026-07-20	2026-07-10	7.19 → 6.44%	+$12K	$1.08

HLB innoVation$3.3M · 2026-10-156.18%

Jin Yang-gon$1.9M · direct 2.16% · indirect 1.27% · avg $2.37 −39% · 2026-10-153.43%+0.86pp

Direct2.16%
HLB 7.15% → HLB Therapeutics 13.64% → HLB Genex 1.74%0.02%
HLB 7.15% → HLB Genex 13.76%0.98%
HLB 7.15% → HLB Panagene 8.44% → HLB Genex 6.24%0.04%
HLB Panagene 1.30% → HLB Genex 6.24%0.08%
HLB Pharmaceutical 2.09% → HLB innoVation 7.84% → HLB Genex 6.18%0.01%
HLB 7.15% → HLB innoVation 16.07% → HLB Genex 6.18%0.07%
HLB innoVation 0.73% → HLB Genex 6.18%0.05%
HLB 7.15% → HLB Life Science 16.81% → HLB Genex 1.74%0.02%

Kim Eui-joong$1.6M · avg $2.42 (partial) · 2026-10-152.92%

HLB Life Science$1.2M · direct 1.74% · indirect 0.56% · avg $2.27 −36% · 2026-10-152.30%

Direct1.74%
HLB Pharmaceutical 14.05% → HLB innoVation 7.84% → HLB Genex 6.18%0.07%
HLB innoVation 7.89% → HLB Genex 6.18%0.49%

HLB Therapeutics$1.0M · direct 1.74% · indirect 0.14% · avg $2.27 −36% · 2026-10-151.88%

Direct1.74%
HLB Panagene 1.30% → HLB Genex 6.24%0.08%
HLB innoVation 0.73% → HLB Genex 6.18%0.05%
HLB Life Science 0.97% → HLB Genex 1.74%0.02%

HLB Investment$1.0M · direct 1.74% · indirect 0.13% · avg $2.27 −36% · 2026-10-151.87%

Direct1.74%
HLB Panagene 1.30% → HLB Genex 6.24%0.08%
HLB innoVation 0.73% → HLB Genex 6.18%0.05%

Epoche$800K · direct 1.42% · indirect 0.05% · avg $2.04 −29% · 2026-10-151.47%

Direct1.42%
HLB innoVation 0.84% → HLB Genex 6.18%0.05%

3 other related parties$650K1.23%

Average cost is the mean purchase price from filings since November 2024. Indirect stakes multiply ownership through listed companies.

Indirect-only holders

Samsung Asset Management$345K · indirect0.64%

HLB 4.09% → HLB Genex 13.76%0.56%
HLB 4.09% → HLB Panagene 8.44% → HLB Genex 6.24%0.02%
HLB 4.09% → HLB innoVation 16.07% → HLB Genex 6.18%0.04%
HLB 4.09% → HLB Life Science 16.81% → HLB Genex 1.74%0.01%

HLB bioStep$309K · indirect0.57%

HLB Panagene 7.14% → HLB Genex 6.24%0.45%
HLB innoVation 2.02% → HLB Genex 6.18%0.12%

HLB Pharmaceutical$275K · indirect0.51%

HLB Therapeutics 1.28% → HLB Genex 1.74%0.02%
HLB innoVation 7.84% → HLB Genex 6.18%0.48%

BlackRock$255K · indirect0.47%

HLB 0.96% → HLB Genex 13.76%0.13%
HLB 0.51% → HLB Genex 13.76%0.07%
HLB 0.14% → HLB Genex 13.76%0.02%
HLB 1.69% → HLB Genex 13.76%0.23%
HLB 1.69% → HLB innoVation 16.07% → HLB Genex 6.18%0.02%

$193K · indirect0.36%

HLB Panagene 5.71% → HLB Genex 6.24%0.36%

$188K · indirect0.35%

HLB innoVation 5.61% → HLB Genex 6.18%0.35%

$165K · indirect0.30%

HLB Panagene 4.87% → HLB Genex 6.24%0.30%

$162K · indirect0.30%

HLB innoVation 4.83% → HLB Genex 6.18%0.30%

$94K · indirect0.17%

HLB 1.17% → HLB Genex 13.76%0.16%
HLB 1.17% → HLB innoVation 16.07% → HLB Genex 6.18%0.01%

$57K · indirect0.11%

HLB 0.18% → HLB Genex 13.76%0.02%
HLB Panagene 1.30% → HLB Genex 6.24%0.08%

No direct stake in the filings. It may be under 5% or filed before November 2024, so actual holdings may be larger.

Show 1 unchanged reports

Filed	Changed	Holder	Change	Before → after	Amount	Avg buy price
2026-08-06	2026-08-05	HLB	No change	38.32 → 38.32%	−$0	$1.64	Filing

45 in the last 2 years · amount = quantity × price per trade in the last year (closing price where no price is filed), avg buy price = average of buys in that filing · change dates and prices only where the original filing was fetched

· avg $2.27 (partial)

· avg $1.08 (partial)

· avg $2.27 (partial)

Jin Yang-gonInsider report